| scholarly article | Q13442814 |
| P50 | author | Joanne E Mortimer | Q56826504 |
| Timothy Synold | Q78536675 | ||
| Arti Hurria | Q88804859 | ||
| P2093 | author name string | Tao Feng | |
| George Somlo | |||
| M Suzette Blanchard | |||
| Vani Katheria | |||
| Anthony Choi | |||
| Arnold J Rotter | |||
| Carol Wong | |||
| Caroline M Doan | |||
| Cathie T Chung | |||
| Jaycen Brown | |||
| Rupal Ramani | |||
| Thehang Luu | |||
| P2860 | cites work | The hospital anxiety and depression scale | Q27860968 |
| The timed "Up & Go": a test of basic functional mobility for frail elderly persons | Q29615553 | ||
| ''R"--project for statistical computing | Q29618640 | ||
| Toxicity and response criteria of the Eastern Cooperative Oncology Group | Q29619399 | ||
| Altered clearance of unbound paclitaxel in elderly patients with metastatic breast cancer | Q33185597 | ||
| Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer | Q36059237 | ||
| Physiologic aspects of aging: impact on cancer management and decision making, part I. | Q36360612 | ||
| Physiologic aspects of aging: impact on cancer management and decision making, part II. | Q36360617 | ||
| Clinical pharmacology of cancer therapies in older adults. | Q36459787 | ||
| Quantitative determination of total and unbound paclitaxel in human plasma following Abraxane treatment | Q36484911 | ||
| Pharmacokinetics of chemotherapy in the older patient. | Q36715263 | ||
| Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study | Q36760924 | ||
| Geriatric assessment is associated with completion of chemotherapy, toxicity, and survival in older adults with cancer | Q36940190 | ||
| Improved targeting of cancer care for older patients: a systematic review of the utility of comprehensive geriatric assessment | Q38144259 | ||
| The MOS social support survey | Q39513264 | ||
| Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score | Q39688507 | ||
| Representation of older patients in cancer treatment trials | Q40704683 | ||
| A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients | Q43763447 | ||
| Geriatric factors predict chemotherapy feasibility: ancillary results of FFCD 2001-02 phase III study in first-line chemotherapy for metastatic colorectal cancer in elderly patients. | Q44732965 | ||
| Phase I and pharmacokinetics trial of ABI-007, a novel nanoparticle formulation of paclitaxel in patients with advanced nonhematologic malignancies | Q46781761 | ||
| The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire | Q52101368 | ||
| Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. | Q52215816 | ||
| Toxicity of Older and Younger Patients Treated With Adjuvant Chemotherapy for Node-Positive Breast Cancer: The Cancer and Leukemia Group B Experience | Q57578427 | ||
| Assessment of older people: self-maintaining and instrumental activities of daily living | Q66829682 | ||
| Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group | Q72274218 | ||
| Underrepresentation of patients 65 years of age or older in cancer-treatment trials | Q73311140 | ||
| A phase II study of weekly paclitaxel in elderly patients with advanced non-small cell lung cancer | Q77372791 | ||
| Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration | Q81002008 | ||
| Prospective evaluation of the relationship of patient age and paclitaxel clinical pharmacology: Cancer and Leukemia Group B (CALGB 9762) | Q82985575 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanoparticle | Q61231 |
| pharmacokinetics | Q323936 | ||
| paclitaxel | Q423762 | ||
| pharmacodynamics | Q725307 | ||
| P304 | page(s) | 37-44 | |
| P577 | publication date | 2014-12-09 | |
| P1433 | published in | Oncologist | Q2122327 |
| P1476 | title | Age-related changes in nanoparticle albumin-bound paclitaxel pharmacokinetics and pharmacodynamics: influence of chronological versus functional age | |
| P478 | volume | 20 |
| Q38726616 | Clinical Pharmacokinetics of Paclitaxel Monotherapy: An Updated Literature Review. |
| Q37325560 | Effect of age on drug metabolism in women with breast cancer |
| Q26745420 | Targeted chemotherapy with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in metastatic breast cancer: which benefit for which patients? |
| Q26785458 | Taxanes in the elderly patient with metastatic breast cancer |
Search more.